StonvexLoading…
StonvexStonvexStonvexCore line items from ACHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $828.80M | $3.31B | $2.49B | $1.64B |
Operating Income | $10.96M | $-1.07B | $103.46M | $63.47M |
Net Income | $4.11M | $-1.18B | $36.25M | $30.13M |
EPS (Diluted) | $0.05 | $-12.16 | $0.82 | $0.42 |
Total Assets | $5.55B | $5.53B | $6.41B | $6.31B |
Total Liabilities | $3.38B | $3.39B | $3.12B | $3.08B |
Cash & Equivalents | $158.47M | $133.24M | $118.69M | $131.42M |
Free Cash Flow OCF − CapEx | $-15.03M | $-439.91M | $-260.43M | $-197.40M |
Shares Outstanding | 90.76M | 90.45M | 90.43M | 90.39M |